The Value of Vaccines in the Avoidance of Antimicrobial Resistance
The issue of antimicrobial resistance (AMR) is widely understood to be one of the most significant threats to global health. Currently AMR has resulted in profound challenges for the treatment of infectious disease especially in low- and middle-income countries as evidenced, for example, by the emergence of antibiotic resistant Typhoid infections. All countries are experiencing a growth in the emergence of resistant organisms, making the treatment of infections - particularly those that are acquired in hospital settings - very difficult.
The United Nations General Assembly recently agreed a political declaration to tackle AMR. Within the declaration, vaccines were identified as one of the proposed solutions for reducing the impact of AMR. However, despite the use of vaccines having been included in the declaration and in other reports, such as Lord O’Neill’s review, the health and economic benefits that result from their role in reducing AMR have been underappreciated.
This roundtable seeks to raise the profile of the health and economic benefits that vaccines hold for the reduction of AMR, and to identify better ways to assign values to these benefits with the aim of improving policy-making.
Attendance at this event is by invitation only.